
Capres 150mg Tablet
Marketer
Resonance Laboratories Pvt Ltd
Salt Composition
Capecitabine (150 mg)
Overview Capres 150mg Tablet
Oncaspar 150mg tablets are indicated for the management of breast, colorectal, and rectal cancers. Additional applications may be prescribed by your physician. It's administered as a component of chemotherapy, either solely or in conjunction with other drugs. Consume Oncaspar 150mg tablets with food, within 30 minutes post-meal. Dosage and frequency are determined by your doctor, based on your condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper usage or overdose can result in severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Frequent side effects include emesis, asthenia, nausea, abdominal discomfort, and diarrhea. This medication can lead to leukocytopenia, increasing infection risk. Regular blood tests monitoring blood cell counts, cardiac function, hepatic function, and uric acid levels are mandatory. Inform your doctor of any pre-existing liver or kidney conditions, or concurrent use of anti-infectives before commencing treatment. Potential drug interactions exist; disclose all medications to your physician. This medication is contraindicated during pregnancy and lactation. Utilizing effective contraception is essential for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Capres 150mg Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of Capres 150mg Tablet
Cancers affecting the breast and colorectal system
Major Benefits of Capres 150mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Capres 150 mg tablets should be administered with food.
Common Side effects of Capres 150mg Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use Capres 150mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Capres 150 mg Tablets should be administered with a meal.
How Capres 150mg Tablet works:
Capres 150 mg tablets contain an anticancer agent that metabolizes into 5-fluorouracil. This metabolite inhibits the production of RNA and DNA within cancerous cells, disrupting their cellular processes and growth. Consequently, the proliferation of malignant cells is suppressed, leading to their eventual demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Capres 150 mg Tablet may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Capres 150 mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where the potential advantages outweigh the dangers. Physician consultation is essential.
Breast feedingUNSAFE
Lactation is contraindicated with Capres 150 mg tablets due to potential infant toxicity.
DrivingUNSAFE
Taking a 150 mg Capres tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Capres 150 mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Capres 150 mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using 150 mg Capres tablets; dosage modification may be necessary. Consult a physician for guidance. The use of 150 mg Capres tablets is contraindicated in patients exhibiting severe renal dysfunction.
What if you forget to take Capres 150mg Tablet :
NA
Facts to Know About Capres 150mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Modified Deoxycytidine |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Metabolic Antagonists |
